Cannabis Wire
Smart coverage of cannabis policy, regulation, and research, by journalists with years of expertise.
Smart coverage of cannabis policy, regulation, and research, by journalists with years of expertise.
Our newsletter delivers unmatched reporting and analysis to subscribers every weekday morning.
Back in August, when the U.S. Senate delayed the implementation of new federal restrictions on intoxicating hemp, they left out one thing: synthetics.
So while other changes, like a .4 mg THC per container cap for hemp-derived products, won’t take effect until December 11, the limits around synthetic cannabinoids in hemp products become law today.
The language around synthetics, however, is vague. It would only ban hemp products that contain “cannabinoids that are not capable of being naturally produced” by the plant. An outstanding question is whether this ban would apply to cannabinoids like, say, delta-8 THC. While delta-8 THC can be “naturally produced” by the plant in tiny quantities, it is almost always produced through conversion of CBD.
Congress tasked the FDA with clearing some of this up. Back in November 2025, when lawmakers crafted the new hemp restrictions and gave the industry one year of breathing room until they took effect, they also gave the FDA 90 days to publish several lists.